Centre de documentation--liste de nouveautés Compilation – volume 1, 2010-2014




старонка6/21
Дата канвертавання26.04.2016
Памер2.58 Mb.
1   2   3   4   5   6   7   8   9   ...   21

Déficience visuelle d’origine corticale

Alimović, S., Jurić, N., & Bošnjak, V.M. (2014). Functional vision in children with perinatal brain damage. Journal of Maternal-Fetal and Neonatal Medicine, 27(14), 1491-1494.

Bergsma, D.P., & Van Der Wildt, G. (2010). Visual training of cerebral blindness patients gradually enlarges the visual field. British Journal of Ophthalmology, 94(1), 88-96.

Bosch, D., Boonstra, F., Willemsen, M., Cremers, F., & de Vries, B. (2014). Low vision due to cerebral visual impairment: differentiating between acquired and genetic causes [ressource électronique]. BMC Ophthalmology, 14(1), 9 pages.

Buetti, S., Tamietto, M., Hervais-Adelman, A., Kerzel, D., Gelder, B. de, & Pegna, A.J. (2013). Dissociation between goal-directed and discrete response localization in a patient with bilateral cortical blindness [ressource électronique]. Journal of Cognitive Neuroscience, 25(10), 1769–1775.

Carré, I. (2012, Septembre). Cécités corticales : Cas cliniques. Bulletin ARIBa, (No 29), 15.

Chokron, S. (2013). La cécité corticale : sémiologie, étiologie et perspectives de prise en charge neuropsychologique. Revue de neuropsychologie, 5(1), 38-44.

Chokron, S. (2014). La cécité corticale. Journal Français d'Ophtalmologie, 37(2), 166-172.

Colenbrander, A. (2010, October). What's in a name? Appropriate terminology for CVI. Journal of Visual Impairment and Blindness, 104(10), 583-585.

Colenbrander, A. (2011, February). Letter to the editor: Further response to the letter to the editor from James E. Jan. Journal of Visual Impairment and Blindness, 105(2), 71-72.

Cyrus, M., & Lunde, F. (2010). Underestimated cerebral visual impairment requires innovative thinking when using AT [Assistive Technology]. Dans K. Miesenberger, J. Klaus, W. Zagler & A. Karshmer (Éds.), Computers Helping People with Special Needs (Vol. 6180, pp. 304 307). Berlin: Springer.

Das, A., & Huxlin, K.R. (2010). New approaches to visual rehabilitation for cortical blindness: Outcomes and putative mechanisms. The Neuroscientist, 16(4), 374-387.

Das, A., Tadin, D., & Huxlin, K.R. (2014). Beyond blindsight: Properties of visual relearning in cortically blind fields. The Journal of Neuroscience, 34(35), 11652-11664.

Erin, J.N. (2010, October). Developing the University curriculum to include CVI: A work in progress at the University of Arizona. Journal of Visual Impairment and Blindness, 104(10), 656-658.

Fook, C.L., Lovett, F., & Dutton, G.N. (2010, October). Cerebral visual impairment in children: A longitudinal case study of functional outcomes beyond the visual acuities. Journal of Visual Impairment and Blindness, 104(10), 625-635.

Gaber, T.A.Z.K. (2010). Rehabilitation of cortical blindness secondary to stroke. NeuroRehabilitation, 27(4), 321-325.

Good, W.V., Hou, C., & Norcia, A.M. (2012). Spatial contrast sensitivity vision loss in children with cortical visual impairment. Investigative Ophthalmology & Visual Science, 53(12), 7730-7734.

Griffin-Shirley, N., & Pogrund, R. (2010, October). Inclusion of CVI in Texas Tech University's Personnel Preparation Program. Journal of Visual Impairment and Blindness, 104(10), 660-661.

Hart, H. (2010). Cognitive and perceptual visual impairment: recognition and intervention. Developmental Medicine and Child Neurology, 52(12), 1075.

Hatton, D.D. (2010, October). Personnel preparation and CVI at Vanderbilt University. Journal of Visual Impairment and Blindness, 104(10), 661-663.

Hyvarinen, L., Appleby, K., Bernas-Pierce, J., Dennison, E., Jackel, B., Lueck, A.H., et al. (2010, Summer). Understanding the complexity of cerebral/cortical visual impairment (C/CVI). AER Report, 27(2), 9, 26 27.

Hyvärinen, L., Nottingham Chaplin, P.K., & Lawrence, L. (2013, September). Profile of visual functioning for CVI and educational assessment . Visibility, 7(2), 1, 3-7.

Iorizzo, D.B., Riley, M.E., Hayhoe, M., & Huxlin, K.R. (2011). Differential impact of partial cortical blindness on gaze strategies when sitting and walking: An immersive virtual reality study. Vision Research, 51(10), 1173-1184.

Jackel, B., Wilson, M., & Hartmann, E. (2010, October). A survey of parents of children with cortical or cerebral visual impairment. Journal of Visual Impairment and Blindness, 104(10), 613-623.

Jan, J.E. (2011, February). Letter to the editor: Cortical visual impairment is not the same as cerebral visual impairment. Journal of Visual Impairment and Blindness, 105(2), 68-70.

Jan, J.E. (2011, March). A final word on neurological visual disorders. Journal of Visual Impairment and Blindness, 105(3), 134-135.

Jan, J.E., Heaven, R.K., Matsuba, C., Langley, M.B., Roman-Lantzy, C., & Anthony, T.L. (2013, July-August). Windows into the visual brain: New discoveries about the visual system, its functions, and implications for practitioners. Journal of Visual Impairment and Blindness, 107(4), 251-261.

Lehman, S.S. (2012). Cortical visual impairment in children: identification, evaluation and diagnosis. Current Opinion in Ophthalmology, 23(5), 384-387.

Lueck, A.H. (2010, October). Cortical or cerebral visual impairment in children: A brief overview. Journal of Visual Impairment and Blindness, 104(10), 585-592.

Lueck, A.H., & Goodrich, G.L. (2011, February). Letter to the editor: Response to the letter to the editor from James E. Jan. Journal of Visual Impairment and Blindness, 105(2), 70-71.

Macintyre-Beon, C., Mitchell, K., Gallagher, I., Cockburn, D., Dutton, G.N., & Bowman, R. (2012, March). My voice heard: The journey of a young man with a cerebral visual impairment. Journal of Visual Impairment and Blindness, 106(3), 166-176.

Macintyre-Béon, C., Young, D., Dutton, G., Mitchell, K., Simpson, J., Loffler, G., et al. (2013). Cerebral visual dysfunction in prematurely born children attending mainstream school. Documenta Ophthalmologica, 127(2), 89-102.

McKenzie, A.R. (2010, October). Personnel preparation for training professionals to work with individuals with CVI at Florida State University. Journal of Visual Impairment and Blindness, 104(10), 655 656.

Markowitz, S.N. (2010). Visual training of cerebral blindness patients gradually enlarges the visual field. Evidence-Based Ophthalmology, 11(3), 154-155.

Martin, T., & Huxlin, K.R. (2010). Spontaneous and training-induced visual learning in cortical blindness: Characteristics and neural substrates. Topics in Cognitive Science, 2(2), 306-319.

Newcomb, S. (2010, October). The reliability of the CVI range: A functional vision assessment for children with cortical visual impairment. Journal of Visual Impairment and Blindness, 104(10), 637-647.

Newcomb, S. (2011, Spring). Functional vision assessment for children with cortical visual impairment [ressource électronique]. Deaf-Blind Perspectives, 18(2).

Philip, S.S., & Dutton, G.N. (2014). Identifying and characterising cerebral visual impairment in children: A review. Clinical and Experimental Optometry, 97(3), 196-208.

Potet, A., Badois-Roux, C., Caron, E., Galland, A., Bruguière, P., Challe, G., et al. (2012). Cécité cérébrale : Évolution et prise en charge en médecine physique et de réadaptation. Revue Neurologique, 168(Supplement 2), A101-A102.

Roman Lantzy, C.A., & Lantzy, A. (2010, October). Outcomes and opportunities: A study of children with cortical visual impairment. Journal of Visual Impairment and Blindness, 104(10), 649-653.

Swaminathan, M. (2011). Cortical visual impairment in children: A new challenge for the future? Oman journal of ophthalmology, 4(1), 1-2.

Trevethan, C.T., Urquhart, J., Ward, R., Gentleman, D., & Sahraie, A. (2012). Evidence for perceptual learning with repeated stimulation after partial and total cortical blindness. Advances in cognitive psychology, 8(1), 29-37.

van Genderen, M., Dekker, M., Pilon, F., & Bals, I. (2012). Diagnosing cerebral visual impairment in children with good visual acuity. Strabismus, 20(2), 78-83.

Watson, T., Orel-Bixler, D., & Haegerstrom-Portnoy, G. (2010). Early visual-evoked potential acuity and future behavioral acuity in cortical visual impairment. Optometry & Vision Science, 87(2), 80-86.



Dégénérescence maculaire

Acton, J.H., Gibson, J.M., & Cubbidge, R.P. (2012). Quantification of visual field loss in age-related macular degeneration [ressource électronique]. PLoS ONE, 7(6), e39944.

The Age-Related Eye Disease Study 2 (AREDS2) Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The age-related eye disease study 2 (areds2) randomized clinical trial. JAMA, 309(19), 2005-2015.

**Alexander, M.S., Lajoie, K., Neima, D.R., Strath, R.A., Robinovitch, S.N., & Marigold, D.S. (2014, August). Effect of ambient light and age-related macular degeneration on precision walking. Optometry & Vision Science, 91(8), 990-999.

Alexander, M.S., Lajoie, K., Neima, D.R., Strath, R.A., Robinovitch, S.N., & Marigold, D.S. (2014). Effects of age-related macular degeneration and ambient light on curb negotiation. Optometry and Vision Science, 91(8), 975-989.

Arbour, J.D. (2010, Avril). La dégénérescence maculaire: Augmenter l’accès aux traitements par la collaboration interprofessionnelle. L’Optométriste, 32(2), 10,12,14-15.

Bailie, M., Wolffsohn, J.S., Stevenson, M., & Jackson, A.J. (2013). Functional and perceived benefits of wearing coloured filters by patients with age-related macular degeneration. Clinical and Experimental Optometry, 96(5), 450-454.

Bandukwala, T., Muni, R.H., Schwartz, C., Eng, K.T., & Kertes, P.J. (2010, December). Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: A retrospective review [ressource électronique]. Canadian Journal of Ophthalmology, 45(6), 590-595.

Barnes, C.S., De l'Aune, W., & Schuchard, R.A. (2011). A test of face discrimination ability in aging and vision loss. Optometry & Vision Science, 88(2), 188-199.

$$Barteselli, G., Gomez, M.L., Doede, A.L., Chhablani, J., Gutstein, W., Bartsch, D.U., et al. (2014). Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects. Eye, 28(10), 1231-1238.

Bennion, A.E., Shaw, R.L., & Gibson, J.M. (2012). What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Social Science & Medicine, 75(6), 976-985.

Bordier, C., Petra, J., Dauxerre, C., Vital-Durand, F., & Knoblauch, K. (2011). Influence of background on image recognition in normal vision and age-related macular degeneration. Ophthalmic and Physiological Optics, 31(3), 203-215.

Bowes Rickman, C., Farsiu, S., Toth, C.A., & Klingeborn, M. (2013). Dry age-related macular degeneration: Mechanisms, therapeutic targets, and imaging. Investigative Ophthalmology & Visual Science, 54(14), ORSF68-ORSF80.

Bozkurt, M.K., Ozturk, B.T., Kerimoglu, H., Ersan, I., Arbag, H., & Bozkurt, B. (2011). Association of age-related macular degeneration with age-related hearing loss. The Journal of Laryngology & Otology, 125(3), 231-235.

Brader, H.S., Ying, G.-s., Martin, E.R., & Maguire, M.G. (2013). Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology, 120(9), 1871-1879.

Bradley, D.T., Zipfel, P.F., & Hughes, A.E. (2011). Complement in age-related macular degeneration: A focus on function. Eye, 25(6), 683 693.

Brennan, M., Horowitz, A., Reinhardt, J.P., Stuen, C., Rubio, R., & Oestreicher, N. (2011, January). The societal impact of age-related macular degeneration: Use of social support resources differs by the severity of the impairment. Journal of Visual Impairment and Blindness, 105(1), 5-19.

Bressler, N.M. (2010). Age-related macular degeneration and its management. Dans A.G. Lee & H.A. Beaver (Éds.), Geriatric Ophthalmology (pp. 49-57). New York: Springer.

Bressler, N.M., Chang, T.S., Varma, R., Suñer, I., Lee, P., Dolan, C.M., et al. ( 2013). Driving ability reported by neovascular age-related macular degeneration patients after treatment with Ranibizumab. Ophthalmology, 120(1), 160-168.

Brody, B.L., Field, L.C., Roch-Levecq, A.-C., Depp, C., Edland, S.D., Minasyan, L., et al. (2012). Computer use among patients with age-related macular degeneration. Ophthalmic Epidemiology, 19(4), 190 195.

Brown, G., & Brown, M. (2010). Let us wake the nation on the treatment for age-related macular degeneration. Current Opinion in Ophthalmology, 21(3), 169-171.

Burton, A.E. (2013, September). Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: A qualitative study. British Journal of Visual Impairment, 31(3), 178-188.

Burton, A.E., Shaw, R.L., & Gibson, J.M. (2013). ‘I'd like to know what causes it, you know, anything I've done?’ Are we meeting the information and support needs of patients with macular degeneration? A qualitative study [ressource électronique]. BMJ Open, 3(11).

Chaine, G., & Grenet, T. (2013). Recommandation de l’HAS [Haute Autorité de Santé] sur la prise en charge diagnostique et thérapeutique de la dégénérescence maculaire liée à l’âge (DMLA). Un travail, une histoire…. Journal Français d'Ophtalmologie, 36(4), 297-298.

Chalam, K.V., Khetpal, V., Rusovici, R., & Balaiya, S. (2011). A review: Role of ultraviolet radiation in age-related macular degeneration. Eye & Contact Lens: Science & Clinical Practice, 37(4), 225-232.

Chew, E.Y., Clemons, T., Agron, E., Sperduto, R.D., Sangiovanni, J.P., Davis, M.D., et al. (2014). Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA ophthalmology, 132(3), 272-277.

Chew, E.Y., Clemons, T., SanGiovanni, J.P., Danis, R., Domalpally, A., McBee, W., et al. (2012). The Age-related Eye Disease Study 2 (AREDS2): Study design and baseline characteristics (AREDS2 report number 1). Ophthalmology, 119(11), 2282-2289.

Choudhury, F., Varma, R., McKean-Cowdin, R., Klein, R., & Azen, S.P. (2011). Risk factors for four-year incidence and progression of age-related macular degeneration: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 152(3), 385-395.

Cimarolli, V.R., Boerner, K., Brennan-Ing, M., Reinhardt, J.P., & Horowitz, A. (2012). Challenges faced by older adults with vision loss: A qualitative study with implications for rehabilitation. Clinical Rehabilitation, 26(8), 748-757.

Cimarolli, V.R., Laban-Baker, A., Hamilton, W.S., & Stuen, C. (2012). Awareness, knowledge, and concern about age-related macular degeneration. Educational Gerontology, 38(8), 530-538.

Cohen, S.Y., Dubois, L., Tadayoni, R., & Quentel, G. (2011). Age at occurrence of exudative age-related macular degeneration in a clinical setting: Difference between 1986 and 2006. Ophthalmologica, 225(2), 76-80.

Cohen, S.Y., & Girmens, J.F. (2011). DMLA: Les traitements à venir. Journal Français d'Ophtalmologie, 34(7), 498-501.

Cohen, S.Y., Mauget-Faysse, M., Oubraham, H., Algan, M., Conrath, J., & Roquet, W. (2010). Impact des habitudes nutritionnelles sur la pathologie maculaire évalué par mesure de la densité optique du pigment maculaire. Journal français d'ophtalmologie, 33(4), 234 240.

Cohen, S.Y., Mimoun, G., Oubraham, H., Zourdani, A., Malbrel, C., Quere, S., et al. (2013). Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal Ranibizumab in daily clinical practice: the LUMIERE study. Retina, 33(3), 474-481

Coleman, A.L., Yu, F., Ensrud, K.E., Stone, K.L., Cauley, J.A., Pedula, K.L., et al. (2010). Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of The Study of Osteoporotic Fractures. American Journal of Ophthalmology, 150(5), 683-691.

Crossland, M., Engel, S.A., & Legge, G.E. (2011). The preferred retinal locus in macular disease: Toward a consensus definition. Retina, 31(10), 2109-2114.

Cruess, A.F., Berger, A., Colleaux, K., Greve, M., Harvey, P., Kertes, P. J., et al. (2012). Canadian expert consensus: Optimal treatment of neovascular age-related macular degeneration. Canadian journal of ophthalmology, 47(3), 227-235.

Curtis, L.H., Hammill, B.G., Qualls, L.G., Dimartino, L.D., Wang, F., Schulman, K.A., et al. (2012). Treatment patterns for neovascular age-related macular degeneration: Analysis of 284 380 medicare beneficiaries. American Journal of Ophthalmology, 153(6), 1116 1124.

Davis, J., Olsen, T.W., Stewart, M., & Sternberg Jr, P. (2011). How the comparison of age-related macular degeneration treatments trial results will impact clinical care. American Journal of Ophthalmology, 152(4), 509-514.

Delcourt, C. (2012, Septembre). ALIENOR – PIMAVOSA : Le rôle protecteur des oméga-3 à longue chaîne dans la DMLA se précise. Bulletin ARIBa, (No 29), 10-12.

Dorrepaal, S.J., & Markowitz, S.N. (2013). Impact of colour in the assessment of potential visual acuity in patients with age-related macular degeneration. Canadian Journal of Ophthalmology, 48(3), 199-203.

Duquette, J. (2013). L’efficacité et l’impact des traitements antiangiogéniques de la dégénérescence maculaire liée à l’âge de forme humide : Document-synthèse de veille informationnelle [ressource électronique]. Longueuil : INLB. 16 p.

Evans, J.R., & Lawrenson, J.G. (2012). Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews(6). 48 p.

Fasser, C., & Buser, F. (2013). La dégénérescence maculaire liée à l’âge : Autonomie dans la vie de tous les jours [ressource électronique] (3e éd. revue). Zurich : Retina Suisse. 11 p.

Feigl, B., & Morris, C.P. (2011). The challenge of predicting macular degeneration. Current Medical Research and Opinion, 27(9), 1745 1748.

Finger, R., Fenwick, E., Pesudovs, K., Marella, M., Lamoureux, E.L., & Holz, F.G. (2012). Rasch analysis reveals problems with multiplicative scoring in the Macular Disease Quality of Life Questionnaire. Ophthalmology, 119(11), 2351-2357.

Finger, R., Hoffmann, A.E., Fenwick, E.K., Wolf, A., Kampik, A., Kernt, M., et al. (2012). Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine. British Journal of Ophthalmology, 96(7), 997-1002

Fletcher, D.C., Schuchard, R.A., & Renninger, L.W. (2012). Patient awareness of binocular central scotoma in age-related macular degeneration. Optometry & Vision Science, 89(9), 1395-1398.

Foster, W.J., Tufail, W., & Issa, A.M. (2010). The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: A systematic review and quantitative appraisal of the evidence. British Journal of Ophthalmology, 94(9), 1118-1126.

France, Haute Autorité de Santé. (2012). Recommandation de bonne pratique : Dégénérescence maculaire liée à l’âge : Prise en charge diagnostique et thérapeutique [ressource électronique]. Saint-Denis La Plaine: HAS. Sommaire des ressources électroniques: Information à donner aux patients; Prise en charge diagnostique; La rééducation de basse vision; Prise en charge thérapeutique par l’ophtalmologiste; Recommandations.

Freund, K.B., Mrejen, S., & Gallego-Pinazo, R. (2013). An update on the pharmacotherapy of neovascular age-related macular degeneration. Expert opinion on pharmacotherapy, 14(8), 1017-1028.

Gehrs, K.M., Jackson, J.R., Brown, E.N., Allikmets, R., & Hageman, G.S. (2010). Complement, age-related macular degeneration and a vision of the future. Archives of Ophthalmology, 128(3), 349-358.

Gill, K., Mao, A., Powell, A. M., & Sheidow, T. (2013). Digital reader vs print media: The role of digital technology in reading accuracy in age-related macular degeneration. Eye, 27(5), 639-643.

**Gopinath, B., Liew, G., Burlutsky, G., & Mitchell, P. (2014). Age-related macular degeneration and 5-year incidence of impaired activities of daily living. Maturitas, 77(3), 263-266.

**Gopinath, B., Liew, G., Burlutsky, G., & Mitchell, P. (2014). Physical activity and the 15-Year incidence of age-related macular degeneration ; Supplemental data. Investigative Ophthalmology & Visual Science, 55(12), 7799-7803.

Hakobyan, L., Lumsden, J., O'Sullivan, D., & Bartlett, H. (2012). Understanding the IT[information technology]-related attitudes and needs of persons with age-related macular degeneration: A case study. Communication présentée à 26th Annual BCS Interaction Specialist Group Conference on People and Computers, Birmingham, United Kingdom.

Hijazi, M.H., Coenen, F., & Zheng, Y. (2012). Data mining techniques for the screening of age-related macular degeneration. Knowledge-Based Systems, 29, 83-92.

Hochstetler, B.S., Scott, I.U., Kunselman, A.R., Thompson, K., & Zerfoss, E. (2010). Adherence to recommendations of the age-related eye disease study in patients with age-related macular degeneration. Retina, 30(8), 1166-1170.

Hodge, W., Brown, A., Cruess, A., Hopkins, R., McGahan, L., Blair, J., Vollman, D.,et al. (2010, June). Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation [ressource électronique]. Canadian Journal of Ophthalmology, 45(3), 223-230.

Holton, B. (2014, January). Three new techniques for treating age-related macular degeneration [ressource électronique]. AccessWorld, 15(1).

Iannaccone, A. (2014). Measuring dark adaptation in the elderly: A predictor of who may develop macular degeneration? Investigative Ophthalmology & Visual Science, 55(8), 4790.

Irons, J., McKone, E., Dumbleton, R., Barnes, N., He, X., Provis, J., et al. (2014). A new theoretical approach to improving face recognition in disorders of central vision: Face caricaturing. Journal of Vision, 14(2), 29 p.

Jackson, G.R., Scott, I.U., Kim, I.K., Quillen, D.A., Iannaccone, A., & Edwards, J.G. (2014). Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Investigative Ophthalmology & Visual Science, 55(3), 1427-1431.

Johnson, A. (2013, March). Investigating eye movements during tasks of daily living. Visibility, 7(1), 13-14.

**Jonas, J.B., Bourne, R.R., White, R.A., Flaxman, S.R., Keeffe, J., Leasher, J., et al. (2014). Visual impairment and blindness due to macular diseases globally: A systematic review and meta-analysis. American Journal of Ophthalmology, 158(4), 808-815.

Jonasson, F., Fisher, D.E., Eiriksdottir, G., Sigurdsson, S., Klein, R., Launer, L.J., et al. (2014). Five-year incidence, progression, and risk factors for age-related macular degeneration: The Age, Gene/Environment Susceptibility Study. Ophthalmology, 121(9), 1766-1772.

Kaarniranta, K., Salminen, A., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011). Age-related macular degeneration (AMD): Alzheimer's disease in the eye? Journal of Alzheimer's Disease, 24(4), 615-631.

Kaiser, P.K., Wang, Y.-Z., He, Y.-G., Weisberger, A., Wolf, S., & Smith, C.H. (2013). Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: Results of a pilot study. Retina, 33(9), 1863-1870.

Keenan, T.D., Goldacre, R., & Goldacre, M.J. (2014). Associations between age-related macular degeneration, alzheimer disease, and dementia: Record linkage study of hospital admissions. JAMA Ophthalmology, 132(1), 63-68

Keenan, T.D., Kelly, S.P., Sallam, A., Mohamed, Q., Tufail, A., & Johnston, R.L. (2013). Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK. British Journal of Ophthalmology, 97(9), 1168-1172.

Kim, B.J., Ying, G.-S., Huang, J., Levy, N.E., & Maguire, M.G. (2014). Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). American Journal of Ophthalmology, 158(1), 128-135.e110.

Klein, B.E., Howard, K.P., Iyengar, S.K., Sivakumaran, T.A., Meyers, K.J., Cruickshanks, K.J., et al. (2014). Sunlight exposure, pigmentation, and incident age-related macular degeneration. Investigative Ophthalmology & Visual Science, 55(9), 5855-5861.

Klein, M.L., Francis, P.J., Ferris, F.L., III, Hamon, S.C., & Clemons, T.E. (2011). Risk assessment model for development of advanced age-related macular degeneration. Archives of Ophthalmology, 129(12), 1543-1550.

Klein, R., Cruickshanks, K.J., Nash, S.D., Krantz, E.M., Nieto, F.J., Huang, G.H., et al. (2010). The prevalence of age-related macular degeneration and associated risk factors. Archives of Ophthalmology, 128(6), 750-758.

Klein, R., Klein, B.E.K., & Myers, C.E. (2011). Risk assessment models for late age-related macular degeneration. Archives of Ophthalmology, 129(12), 1605-1606.

Klein, R., Lee, K.E., Gangnon, R.E., & Klein, B E. (2014). Relation of smoking, drinking, and physical activity to changes in vision over a 20-year period: The Beaver Dam Eye Study. Ophthalmology, 121(6), 1220-1228.

Kowluru, R.A., & Zhong, Q. (2011). Beyond AREDS: Is there a place for antioxidant therapy in the prevention/treatment of eye disease [Age-related macular degeneration; diabetic retinopathy]? Investigative Ophthalmology & Visual Science, 52(12), 8665-8671.

Krüger Falk, M., Kemp, H., & Sørensen, T.L. (2013). Four-year treatment results of neovascular age-related macular degeneration with Ranibizumab and causes for discontinuation of treatment. American Journal of Ophthalmology, 155(1), 89-95.e83.

Kumar, G., & Chung, S.T. (2014). Characteristics of fixational eye movements in people with macular disease. Investigative Ophthalmology & Visual Science, 55(8), 5125-5133.

Lagacé, J.-P. (2010, Avril). Traitements de la DMLA: Revue. L’Optométriste, 32(2), 16-19.

Lagacé, J.-P. (2012, Juillet/août). Les médicaments antiangiogéniques dans le traitement de la dégénérescence maculaire liée à l’âge : Nouvelles données cliniques. L’Optométriste, 34(4), 8-16.

Lamoureux, E.L., Mitchell, P., Rees, G., Cheung, G., Yeo, I., Lee, S.Y., et al. (2011). Impact of early and late age-related macular degeneration on vision-specific functioning. British Journal of Ophthalmology, 95(5), 666-670.

Lawrenson, J.G., & Evans, J.R. (2012). Omega 3 fatty acid supplementation for preventing and slowing the progression of age-related macular degeneration. [Protocol]. Cochrane Database of Systematic Reviews(8), 9 p.

Lecerf, J.M., & Desmettre, T. (2010). Nutrition et dégénérescence maculaire liée à l'âge. Journal Français d'Ophtalmologie, 33(10), 749-757.

Lee, K.K., & Markowitz, S.N. (2010, August). Scotoma size reduction as an adaptive strategy in age-related macular degeneration [ressource électronique]. Canadian Journal of Ophthalmology, 45(4), 393-398.

Leveziel, N., Delcourt, C., Zerbib, J., Dollfus, H., Kaplan, J., Benlian, P., et al. (2009). Épidémiologie de la dégénérescence maculaire liée à l'âge. Journal français d'ophtalmologie, 32(6), 440-451.

Lim, L.S., Mitchell, P., Seddon, J.M., Holz, F.G., & Wong, T.Y. (2012). Age-related macular degeneration. The Lancet, 379(9827), 1728 1738.

Liu, L., Wang, Y.Z., & Bedell, H.E. (2014). Visual-function tests for self-monitoring of age-related macular degeneration. Optometry and Vision Science, 91(8), 956-965.

Liu, L., & White, J. (2010). Early age-related macular degeneration impairs tolerance to stimulus degradation. Optometry & Vision Science, 87(8), 532-542.

Loughman, J., Hewitt, C., Judge, C., Martin, L., Moulds, C., & Davison, P. A. (2013). Clinical applicability of the Macular Degeneration Detection Device (MDD-2): A novel photostress recovery measurement device. Clinical and Experimental Optometry, 96(3), 272-277.

Lovie–Kitchin, J. (2011). Reading with low vision: The impact of research on clinical management. Clinical and Experimental Optometry, 94(2), 121-132.

McGrath, L.A., & Lee, L.R. (2013). Characteristics of patients who drop out grom Ranibizumab terapy. Asia-Pacific Journal of Ophthalmology, 2(5), 295-299.

McGwin, G., Mitchell, B., Searcey, K., Albert, M.A., Feist, R., Mason, J.O., et al. (2013). Examining the association between age-related macular degeneration and motor vehicle collision involvement: A retrospective cohort study. British Journal of Ophthalmology, 97(9), 1173-1176.

Markowitz, S.N., Reyes, S.V., & Sheng, L. (2013). The use of prisms for vision rehabilitation after macular function loss: an evidence-based review. Acta Ophthalmologica, 91(3), 207-211.

**Markun, S., Brändle, E., Dishy, A., Rosemann, T., & Frei, A. (2014). The concordance of care for age related macular degeneration with the chronic care model: A multi-centered cross-sectional study [ressource électronique]. PLoS ONE, 9(10), e108536.

Mathew, R.S., Delbaere, K., Lord, S.R., Beaumont, P., Vaegan, & Madigan, M.C. (2011). Depressive symptoms and quality of life in people with age-related macular degeneration. Ophthalmic and Physiological Optics, 31(4), 375-380.

Menke, M.N., Zinkernagel, M.S., Ebneter, A., & Wolf, S. (2014). Functional and anatomical outcome of eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab following an exit strategy regimen. British Journal of Ophthalmology, 98(9), 1197-1200.

Miller, J.W. (2013). Age-related macular degeneration revisited – piecing the puzzle: The LXIX Edward Jackson Memorial Lecture. American Journal of Ophthalmology, 155(1), 1-35.e13.

Mitchell, P., Bressler, N., Doan, Q.V., Dolan, C., Ferreira, A., Osborne, A., et al. (2014). Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by Ranibizumab treatment. [ressource électronique]. PLoS ONE, 9(6), e101072.

Montgomery, M.P., Kamel, F., Pericak-Vance, M.A., Haines, J.L., Postel, E.A., Agarwal, A., et al. (2010). Overall Diet Quality and Age-Related Macular Degeneration. Ophthalmic Epidemiology, 17(1), 58 65.

Munch, I.C., Linneberg, A., & Larsen, M. (2013). Precursors of age-related macular degeneration: Associations with physical activity, obesity, and serum lipids in the Inter99 Eye Study. Investigative Ophthalmology & Visual Science, 54(6), 3932-3940.

Musel, B., Hera, R., Chokron, S., Alleysson, D., Chiquet, C., Romanet, J.-P., et al. (2011). Residual abilities in age-related macular degeneration to process spatial frequencies during natural scene categorization. Visual Neuroscience, 28(6), 529-541.

Ngai, L.Y., Stocks, N., Sparrow, J.M., Patel, R., Rumley, A., Lowe, G., et al. (2011). The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom. Eye, 25(6), 784-793.

Nguyen, N.X., & Trauzettel-Klosinski, S. (2009). Effectiveness of magnifying low vision aids in patients with age-related macular degeneration. Neuro-Ophthalmology, 33(3), 115-119.

Nguyen, N.X., Weismann, M., & Trauzettel-Klosinski, S. (2009). Improvement of reading speed after providing of low vision aids in patients with age-related macular degeneration. Acta Ophthalmologica, 87(8), 849-853.

Nivison-Smith, L., Milston, R., Madigan, M., & Kalloniatis, M. (2014). Age-related macular degeneration: linking clinical presentation to pathology. Optometry and Vision Science, 91(8), 832-848.

Noble, J.M., & Chaudhary, V.M. (2010). Age-related macular degeneration. Canadian Medical Association Journal, 182(16), 1759.

O’Neill-Biba, M., Sivaprasad, S., Rodriguez-Carmona, M., Wolf, J.E., & Barbur, J.L. (2010). Loss of chromatic sensitivity in AMD and diabetes: A comparative study. Ophthalmic and Physiological Optics, 30(5), 705-716.

Owen, C.G., Jarrar, Z., Wormald, R., Cook, D.G., Fletcher, A.E., & Rudnicka, A.R. (2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. British Journal of Ophthalmology, 96(5), 752-756.

Pardhan, S., Gonzalez-Alvarez, C., Subramanian, A., & Chung, S.T. (2012). How do flanking objects affect reaching and grasping behavior in participants with macular disorders? Investigative Ophthalmology & Visual Science, 53(10), 6687-6694.

Passarelli, M. (2010, Juillet/août). Progrès en matière de traitement de la dégénérescence maculaire liée à l’âge (DMLA). L’Optométriste, 32(4), 14-16.

Payakachat, N., Summers, K.H., Pleil, A.M., Murawski, M.M., Thomas, J., Jennings, J., et al. (2009). Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Quality of Life Research, 18(7), 801-813.

Piponnier, J.-C. (2012, Mars/avril). Bénéfices de l’apport alimentaire en w3 dans la prévention et le traitement de la dégénérescence maculaire liée à l’âge. L'Optométriste, 34(2), 20-22.

Prasad, P.S., Schwartz, S.D., & Hubschman, J.-P. (2010). Age-related macular degeneration: Current and novel therapies. Maturitas, 66(1), 46-50.

Rathore, D., Oyede, T., Narendran, N., & Yang, Y.C. (2012, September). Snellen versus logMAR visual acuity charts for evaluating driving standards in patients with neovascular macular degeneration. British Journal of Visual Impairment, 30(3), 160-167.

Rein, D.B., Wittenborn, J.S., Zhang, X., Honeycutt, A.A., Lesesne, S.B., & Saaddine, J. (2009). Forecasting age-related macular degeneration through the year 2050: The potential impact of new treatments. Archives of Ophthalmology, 127(4), 533-540.

Riazi, A., Dain, S.J., Boon, M.Y., & Bridge, C. (2011). Innovative strategies for adaptation to loss of vision. Clinical and Experimental Optometry, 94(1), 98-102.

RNIB. (2013). Don't lose sight! Don't delay! : Perspectives on the wet age-related macular degeneration (wet AMD) patient journey: RNIB campaign report [ressource électronique]. Londres: RNIB.

Roberts, J.E. (2011). Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye & Contact Lens: Science & Clinical Practice, 37(4), 246-249.

Ronald, K. (2011). Race/ethnicity and age-related macular degeneration. American Journal of Ophthalmology, 152(2), 153-154.

Rovner, B.W., Casten, R.J., Hegel, M.T., Massof, R.W., Leiby, B.E., & Tasman, W.S. (2011). Improving function in age-related macular degeneration: Design and methods of a randomized clinical trial. Contemporary Clinical Trials, 32(2), 196-203.

**Rovner, B.W., Casten, R.J., Hegel, M.T., Massof, R.W., Leiby, B.E., Ho, A.C., & Tasman, W.S. (2014). Low vision depression prevention trial in age-related macular degeneration: A randomized clinical trial. Ophthalmology, 121(11), 2204-2211.

Rovner, B.W., Casten, R.J., Hegel, M.T., Massof, R.W., Leiby, B.E., Ho, A.C., & Tasman, W.S. (2014, May-June). Personality and functional vision in older adults with age-related macular degeneration. Journal of Visual Impairment and Blindness, 108(3), 187-199.

Rovner, B.W., Casten, R.J., Massof, R.W., Leiby, B.E., & Tasman, W.S. (2011). Psychological and cognitive determinants of vision function in age-related macular degeneration. Archives of Ophthalmology, 129(7), 885-890.

Rozzini, L., Riva, M., Ghilardi, N., Facchinetti, P., Forbice, E., Semeraro, F., et al. (2014). Cognitive dysfunction and age-related macular degeneration. American Journal of Alzheimer's Disease and Other Dementias, 29(3), 256-262.

Rubin, G.S., & Feely, M. (2009). The Role of eye movements during reading in patients with age-related macular degeneration (AMD). Neuro-Ophthalmology, 33(3), 120-126.

Rudnicka, A.R., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A., & Owen, C.G. (2012). Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology, 119(3), 571-580.

Rung, L., & Lovestam-Adrian, M. (2013). Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration. Clinical Ophthalmology, 7, 395-401.

Schalnus, R., Meyer, C.H., Kuhli-Hattenbach, C., & Lüchtenberg, M. (2010). Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization. Ophthalmologica, 224(3), 176-182.

Schmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., et al. (2014). Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) [ressource électronique]. British Journal of Ophthalmology, 98(9), 1144-1167.

Schmier, J. K., Covert, D.W., & Lau, E.C. (2012). Patterns and costs associated with progression of age-related macular degeneration. American Journal of Ophthalmology, 154(4), 675-681.

Schoessow, K.A., Fletcher, D.C., & Schuchard, R.A. (2012, December). Preferred retinal loci relationship to macular scotomas: A 10-year comparison. Journal of Visual Impairment and Blindness, 106(11), 745-750.

Seiple, W., Grant, P., & Szlyk, J.P. (2011). Reading rehabilitation of individuals with AMD: Relative effectiveness of training approaches. Investigative Ophthalmology & Visual Science, 52(6), 2938-2944.

Seiple, W., Rosen, R.B., & Garcia, P.M. (2013). Abnormal fixation in individuals with age-related macular degeneration when viewing an image of a face. Optometry & Vision Science, 90(1), 45-56.

Sennlaub, F., & Inserm. (2014, juin). Dégénérescence maculaire liée à l’âge (DMLA) [ressource électronique]. Paris : Inserm.

Semes, L., & Shechtman, D.L. (2010, Septembre/octobre). Mise à jour sur les suppléments nutritionnels et la DMLA. L’Optométriste, 32(5), 7-8,10,12,14.

Shah, S.U., Pilli, S., Telander, D.G., Morse, L.S., & Park, S.S. (2013). Survey of patients with age-related macular degeneration: knowledge and adherence to recommendations. Canadian Journal of Ophthalmolog, 48(3), 204-209.

**Sharma, H. E., Mathewson, P. A., Lane, M., Shah, P., Glover, N., Palmer, H., et al. (2014). The role of social deprivation in severe neovascular age-related macular degeneration. British Journal of Ophthalmology, 98(12), 1625-1628.

**Sheldon, S., Quint, J., Hecht, H., & Bowers, A.R. (2014). The effect of central vision loss on perception of mutual gaze. Optometry and Vision Science, 91(8), 1000-1011.

Siemsen, D.W., & Brown, W.L. (2011). Vision rehabilitation of persons with age related macular degeneration. Seminars in Ophthalmology, 26(3), 65-68.

Sörensen, S., & White, K. (2014, July). Effects of vision education classes on the well-being of older adults with macular degeneration. Visibility, 8(1), 8-9.

Souied, E.H., & Leveziel, N. (2012). Toward personalized medicine for age-related macular degeneration. American Journal of Ophthalmology, 154(3), 427-428.

Stein, J.D., Newman-Casey, P.A., Mrinalini, T., Lee, P.P., & Hutton, D.W. (2014). Cost-effectiveness of Bevacizumab and Ranibizumab for newly diagnosed neovascular macular degeneration. Ophthalmology, 121(4), 936-945.

Stevens, R., Bartlett, H., Walsh, R., & Cooke, R. (2014, May). Age-related macular degeneration patients’ awareness of nutritional factors. British Journal of Visual Impairment, 32(2), 77-93.

Sui, G.-Y., Liu, G.-C., Liu, G.-Y., Gao, Y.-Y., Deng, Y., Wang, W.-Y., et al. (2013). Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis. British Journal of Ophthalmology, 97(4), 389-394.

Swanson, M.W. (2014). Smoking deception and age-related macular degeneration. Optometry and Vision Science, 91(8), 865-671

Tarita-Nistor, L., Brent, M.H., Steinbach, M.J., & González, E.G. (2011). Fixation stability during binocular viewing in patients with age-related macular degeneration. Investigative Ophthalmology & Visual Science, 52(3), 1887-1893.

Tarita-Nistor, L., Brent, M.H., Steinbach, M.J., & Gonzalez, E.G. (2012). Fixation patterns in maculopathy: From binocular to monocular viewing. Optometry & Vision Science, 89(3), 277-287.

Tarita-Nistor, L., Lam, D., Brent, M.H., Steinbach, M.J., & González, E.G. (2013). Courier: A better font for reading with age-related macular degeneration. Canadian Journal of Ophthalmology, 48(1), 56-62.

Thetford, C., Hodge, S., Harding, S., Taylor, S., & Knox, P. C. (2013). Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections. British Journal of Visual Impairment, 31(2), 89-101.

Thomas Pocklington Trust. (2011, January). Blue light and age-related macular degeneration (AMD): Avenues for research [ressource électronique]. Research Discussion Paper, (6), 16 p.

Timberlake, G.T., Bothwell, R.J., & Moyer, K. (2013). Handwriting with a preferred retinal locus for AMD with scotomas. Optometry & Vision Science, 90(5), 455-465.

Timberlake, G.T., Omoscharka, E., Grose, S.A., & Bothwell, R. (2012). Preferred retinal locus—Hand coordination in a maze-tracing task. Investigative Ophthalmology & Visual Science, 53(4), 1810-1820.

Tran, T.H., & Boucart, M. (2012). La perception des objets et des scènes naturelles dans la dégénérescence maculaire liée à l’âge. Journal Français d'Ophtalmologie, 35(1), 58-68.

Tran, T.H., & Boucart, M. (2011, Septembre). La reconnaissance des objets et des scènes naturelles dans la DMLA. Bulletin ARIBa, (No 27), 6-8.

Tran, T.H., Despretz, P., & Boucart, M. (2012). Scene perception in age-related macular degeneration: The effect of contrast. Optometry & Vision Science, 89(4), 419-425.

**Tran, T.H., Despretz, P., & Boucart, M. (2014). Space representation in age-related macular degeneration. Optometry and Vision Science, 91(8), 1012-1020.

Tran, T.H., Guyader, N., Guerin, A., Despretz, P., & Boucart, M. (2011). Figure ground discrimination in age-related macular degeneration. Investigative Ophthalmology & Visual Science, 52(3), 1655-1660.

Tran, T.H., Rambaud, C., Despretz, P., & Boucart, M. (2010). Scene perception in age-related macular degeneration. Investigative Ophthalmology & Visual Science, 51(12), 6868-6874.

Troutbeck, R., Al-Qureshi, S., & Guymer, R.H. (2012). Therapeutic targeting of the complement system in age-related macular degeneration: A review. Clinical & Experimental Ophthalmology, 40(1), 18-26.

Ugurlu, N., Aşık, M.D., Yülek, F., Neselioglu, S., & Cagil, N. (2013). Oxidative stress and anti-oxidative defence in patients with age-related macular degeneration. Current Eye Research, 38(4), 497-502.

U.K. The Royal College of Ophthalmologists. (2013). Age-related macular degeneration:Guidelines for management [ressource électronique]. London: The Royal College of Ophthalmologists. 145 p.

van Nispen, R.M.A., de Boer, M.R., & van Rens, G.H.M.B. (2009). Additional psychometric information and vision-specific questionnaires are available for age-related macular degeneration. Quality of Life Research, 18(1), 65-69.

Vanderbeek, B.L., Zacks, D.N., Talwar, N., Nan, B., Musch, D.C., & Stein, J.D. (2011). Racial differences in age-related macular degeneration rates in the United States: A longitudinal analysis of a managed care network. American Journal of Ophthalmology, 152(2), 273-282.

Varma, R., Foong, A.W.P., Lai, M.-Y., Choudhury, F., Klein, R., & Azen, S.P. (2010). Four-year incidence and progression of age-related macular degeneration: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 149(5), 741-751.

Viana, J., Rossiter, S., Channon, A.A., Brailsford, S.C., & Lotery, A. (2012). A multi-paradigm, whole system view of health and social care for age-related macular degeneration. Communication présenté à Winter Simulation Conference

Vishwanathan, R., Chung, M., & Johnson, E.J. (2013). A Systematic review on zinc for the prevention and treatment of age-related macular degeneration. Investigative Ophthalmology & Visual Science, 54(6), 3985-3998.

Vujosevic, S., Smolek, M.K., Lebow, K.A., Notaroberto, N., Pallikaris, A., & Casciano, M. (2011). Detection of macular function changes in early (AREDS 2) and intermediate (AREDS 3) age-related macular degeneration. Ophthalmologica, 225(3), 155-160.

Watkinson, S. (2010). Management of older people with dry and wet age-related macular degeneration. Nursing Older People, 22(5), 21-26.

Whitson, H.E., Whitaker, D., Sanders, L.L., Potter, G.G., Cousins, S.W., Ansah, D., et al. (2012). Memory deficit associated with worse functional trajectories in older adults in low-vision rehabilitation for macular disease. Journal of the American Geriatrics Society, 60(11), 2087-2092.

Williams, T., Reeves, B.C., Foss, A.E., & Fell, G. (2012). Risks of adverse events with therapies for age-related macular degeneration: A response. Archives of Ophthalmology, 130(1), 124-126.

Wong, I., Koo, S., & Chan, C. (2011). Prevention of age-related macular degeneration. International Ophthalmology, 31(1), 73-82.

Wong, W.L., Su, X., Li, X., Cheung, C.M., Klein, R., Cheng, C.-Y., et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health, 2(2), e106-e116.

Woo, S.J., Park, K.H., Ahn, J., Choe, J.Y., Jeong, H., Han, J.W., et al. (2012). Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology, 119(10), 2094-2101.

**Wu, J., Uchino, M., Sastry, S.M., & Schaumberg, D.A. (2014). Age-related macular degeneration and the incidence of cardiovascular disease: A systematic review and meta-analysis [ressource électronique]. PLoS ONE, 9(3), e89600.

Yehoshua, Z., & Rosenfeld, P.J. (2012). Strategies for following dry age-related macular degeneration. Ophthalmic Research, 48(Suppl. 1), 6 10.

Yoshikawa, T., Ogata, N., Wada, M., Otsuji, T., & Takahashi, K. (2011). Characteristics of age-related macular degeneration in patients with diabetic retinopathy. Japanese Journal of Ophthalmology, 55(3), 235-240.

Yu, Y., Reynolds, R., Rosner, B., Daly, M.J., & Seddon, J.M. (2012). Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multi-state Markov models. Investigative Ophthalmology & Visual Science, 53(3), 1548 1556.

Zanlonghi, X. (2014). MLA et DMLA et conduite [ressource électronique]. [s.l.] : www.bassevison.net. 9 p.

1   2   3   4   5   6   7   8   9   ...   21


База данных защищена авторским правом ©shkola.of.by 2016
звярнуцца да адміністрацыі

    Галоўная старонка